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Abstract 15 
 16 
Monocytes and macrophages belong to the mononuclear phagocyte system and play important roles 17 
in both physiological and pathological processes. The cells belonging to the monocyte/macrophage 18 
system are structurally and functionally heterogeneous. Several subsets of monocytes have been 19 
previously identified in mammalian blood, generating different subpopulations of macrophages in 20 
tissues. Although their distribution and phenotype are similar to their human counterpart, bovine 21 
monocytes and macrophages feature differences in both functions and purification procedures. The 22 
specific roles that monocytes and macrophages fulfil in several important diseases of bovine species, 23 
including among the others tuberculosis and paratuberculosis, brucellosis or the disease related to 24 
peripartum, remain still partially elusive. The purpose of this review is to discuss the current 25 
knowledge of bovine monocytes and macrophages. We will describe methods for their purification 26 
and characterization of their major functions, including chemotaxis, phagocytosis and killing, 27 
oxidative burst, apoptosis and necrosis. An overview of the flow cytometry and morphological 28 
procedures, including cytology, histology and immunohistochemistry, that are currently utilized to 29 
describe monocyte and macrophage main populations and functions is presented as well. 30 
 31 
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1. Introduction: monocytes/macrophages and their main functions. 35 
 36 
Monocytes are myeloid cells produced by the bone marrow that play pivotal roles in the immune 37 
response against infections and injuries. Monocytes and their corresponding tissue derivates, 38 
including macrophages and subpopulations of dendritic cells, are involved in almost all phases of the 39 
inflammation and bridge innate and specific immune responses [1]. In the bone marrow, 40 
hematopoietic stem cells differentiate to precursor cells. Pre-monocytic cells produce peripheral 41 
blood monocytes that transform into resident macrophages upon tissue entry [2]. Resident 42 
macrophages are among the first cell populations to sense a tissue pathogen or injury and generate 43 
the initial wave of cytokines and chemokines, alerting the immune system to incoming pathogens or 44 
tissue damage, skewing immune defences and activating and recruiting additional immune cells at 45 
the site of inflammation [2]. Functions of macrophages vary according to their location and type of 46 
activation. Alveolar macrophages are located in the lungs, and provide cellular defence against 47 
inhaled antigens, clearing the air spaces of infectious, toxic, or allergic particles that have evaded the 48 
mechanical defences of the respiratory tract [3,4]. In the brain, macrophages are identified as resident 49 
microglial cells and protect the Central Nervous System (CNS). Microglial macrophages play a 50 
pivotal role in synaptic pruning during development [5]. In a healthy status, microglia facilitate 51 
learning and memory and scavenge cellular or other debris. After CNS infections and injury, activated 52 
microglia fulfil the functions of resident macrophages during inflammation, recognizing pathogens 53 
or injured cells, activating phagocytic, antigen-presenting and cytokine/chemokine secretion 54 
functions. Activated microglia also contribute to the resolution of inflammation via switching to anti-55 
inflammatory cytokine patterns, and promote intercellular matrix synthesis and angiogenesis.[6]. In 56 
the CNS, beside microglia, macrophages are also found in perivascular, meningeal and choroid plexus 57 
spaces, participating to the blood-brain barrier by modulating the entrance and the phenotype of 58 
immune cells during inflammation [7]. In lymph nodes, macrophages are classified as spinal or 59 
subcapsular sinusoidal, their main role being that of capturing antigens and presenting them to B cells 60 
[8]. The intestine provides one of the largest pool of macrophages in the body. Resident macrophages 61 
act as sentinels for pathogen recognition and elimination, maintaining the intestinal homeostasis by 62 
shaping host-microbiota symbiosis and regulating gut inflammation, promoting the crosstalking with 63 
T cells [9,10]. The splenic red pulp is a large tissue compartment containing macrophage lines able 64 
to perform several and diverse functions. The main role of splenic red pulp macrophages is to engulf 65 
senescent and altered erythrocytes, break down haemoglobin, recovering iron to the bone marrow, 66 
thus contributing to iron homeostasis [11] and to monitor, detect and phagocytize bloodborne 67 
pathogens. Other equally important functions of splenic red pulp macrophages include presenting 68 
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antigens to T lymphocytes of the splenic periarteriolar sheats [12]. In the liver, finally, resident 69 
macrophages are named Kupffer cells. In humans, Kupffer cells account for a large pool of tissue 70 
macrophages, and their main role is to remove toxins and pathogens [13]. 71 
Although the main role of macrophages is related to the protection against pathogens, they contribute 72 
to the resolution of inflammation by at least three ways: a) removing the pathologic stimulus by 73 
phagocytosis; b) producing anti-inflammatory cytokines, including for example TNF- soluble 74 
receptor of IL1-R antagonist and c) removing leukocytes and necrotic debris in the inflammatory site. 75 
Macrophages carry out also tissue-repairing function and actively participate in the development of 76 
many autoimmune diseases development [1].  77 
Peripheral blood (circulating) monocytes are cells with a consistent morphology (Fig. 1), and for 78 
many years they were regarded as a single functional population identified by the surface expression 79 
of the lipopolysaccharide receptor (CD14). However, the development of flow cytometry and multi-80 
colour immunofluorescence, have allowed more detailed differentiation of monocytes, based on the 81 
additional expression of CD16 (FcIIIR), the low-affinity receptor for the Fc regions of IgG [14]. 82 
According to CD14 and CD16 expression over the surface of the cells, at least two subpopulations of 83 
human monocytes: (CD14++(bright)CD16−and CD14+(dim)CD16+) have been identified. Further 84 
studies introduced, according with CD16 intensity of expression, other monocyte subpopulations, 85 
namely CD14++CD16+ and CD14+CD16++ [15]. Given their CD14 and CD16 membrane surface 86 
asset, circulating human blood monocytes can be divided into three different subpopulations [16]:  87 
a) Classical monocytes (cM): “CD14++ CD16− “cells providing approximately 90% of human 88 
blood monocytes. 89 
b) Intermediate monocytes (intM): “CD14++ CD16+ cells” (approximately 10% of human blood 90 
monocytes)  91 
c) Non-classical monocytes (ncM): “CD14+ CD16++” cells (in humans, a population with 92 
variable percentage). 93 
Similar to humans, three monocyte subsets have been identified in bovine peripheral blood as well 94 
[17,18]. The heterogeneity and the functional differences between the three populations of bovine 95 
monocytes have been recently and extensively reviewed [19]. The authors compared bovine 96 
monocytes with their analogue human population, focusing on sub-type distribution and their main 97 
inflammatory functions, including adhesion and chemotaxis. Indeed, bovine monocyte specific 98 
functions (Table 1) have been studied in a relatively limited number of papers [18–20] and only 99 
partially resemble those of human counterparts. 100 
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Table 1 101 
 102 
The inflammatory activity of bovine monocytes subsets 
Sub-type of monocytes Relative 
percentage 
Phagocytic 
capability 1 
ROS 
production2 
Inflammasome 
activation 
Classical monocytes (cM) 
CD14++CD16- 
89% +++ ++ ++ 
Intermediate monocytes (intM) 
CD14++CD16- 
5-10% ++ +++ +++ 
Non-classical monocytes 
(ncM) CD14+CD16++ 
5/10% + + + 
 103 
1 Phagocytic capability is expressed as percentage of FITC-positive cells within viable monocytes 104 
[18]: +++ = 80%, ++ = 56%, + = 40% 105 
2 ROS production is expressed in Mean Fluorescence intensity (MFI). +++ = 30 x 103, ++ = 50 x 106 
103, + = 5 x 103. 107 
3 IL1 production (pg/mL) after ATP and LPS stimulation. +++ 4000 pg/mL, ++1000 pg/mL, + 108 
negligible 109 
 110 
Differences between macrophage activation patterns 1q1q2ubetween cattle and other species also 111 
exist. For example, stimulating bovine monocyte-derived macrophages with pro-inflammatory 112 
signals do not produce the same reactions as compared to human and murine macrophages [19,21].  113 
In humans and rodents, several other macrophage categories have been reviewed [22], the most 114 
important of which are listed in Table 2. The presence of most of these sub-groups in bovine 115 
peripheral blood has yet to be demonstrated. 116 
Table 2 117 
Principal macrophage subcategories and phenotypes in human and rodents 118 
Macrophages 
sub-group 
Type of response Activity Reference 
M1 Pro-inflammatory,  Facilitate immunity to remove foreign 
pathogens and tumour cells, mediate tissue 
damage induced by ROS, impair wound 
healing and tissue regeneration 
[22,23] 
M2 Anti-inflammatory  [24] 
   M2a  Tissue repair and wound healing [25,26] 
M2b  Stress oxidative, efferocytosis [27] 
M2c  Pro-fibrotic activity phagocytosis of 
apoptotic cells 
 
M2d  Tumour-associated macrophages, 
angiogenesis and cancer metastasis 
[28] 
M3 Pro-inflammatory Switch between M2 to M1 response,  
anti-tumour effect 
[29,30] 
M4 Pro-inflammatory Predominant in atherosclerotic lesions [31] 
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low phagocytosis capability, high tissue 
repair capability 
M17 Pro-inflammatory Increased phagocytosis in the presence of 
oxidized LDL 
[21,32] 
Mreg Anti-inflammatory Produce high levels of nitric oxide, CD86 and 
MHC Class II,  
Intense activation and proliferation, of IL-10 
producing T cells  
[33] 
Mox No clear pro- or 
anti-inflammatory 
activity 
Weak phagocytosis, proatherogenic 
Development in response to oxidative stress 
damage 
[34,35] 
 119 
The transcriptomic data also revealed differential gene transcription between the three major 120 
monocyte subclasses of genes involved in immune defences, providing the evidence that monocytes 121 
subsets express different transcriptomes [36]. Indeed, the functions related to CD16+ have to be 122 
revised and probably attributed between intermediate and non-classical subsets [37,38]. A sequential 123 
development between the two subsets was suggested [39], based on the concept that macrophages 124 
adopt in vivo several functional phenotypes, depending on continuous changes of the tissues' 125 
microenvironments. Given this background,  M1/M2 and other subgroups are therefore not definite 126 
subsets but may represent the extremes of a continuum of different functional states [40]. 127 
 128 
2. Purification of bovine monocytes from blood: sorting or adherence  129 
 130 
Normal blood values for monocytes in cows range from 25 to 840 cells/L (average 400 cells/L) 131 
and changes with age [41]. Purification of bovine monocytes starts from the collection of peripheral 132 
blood from the jugular or coccygeal veins, using a sterile Vacutainer™ blood collection vial 133 
containing EDTA (Becton Dickinson, USA). When a large amount of blood is needed (e.g. more than 134 
200 L) the use of blood bags containing citrate phosphate dextrose (Terumo, Japan) is preferred as 135 
a less stressful procedure for the animal. Blood collection must be as fast as possible for welfare 136 
issues and because the production of glucocorticoids associated with prolonged containment can 137 
profoundly affect in vitro monocyte activities. Although published several years ago, the paper by 138 
Godderies and co-workers [42] still provides a very good background for monocyte purification from 139 
bovine blood, specifically for the techniques related to adherence to glass or plastic wares. In general, 140 
methods to purify monocytes can be divided into two groups: those related to the adhesive capability 141 
of monocytes and those related to monocyte sorting by magnetic-activated cell sorting (MACS, 142 
Miltenyi Biotec, Germany). 143 
The purification procedure based on the adhesiveness to tissues has been previously described by the 144 
team of Godderies and coworkers [42], whereas the procedure for the monocyte sorting by MACS 145 
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technique has been first described by Ceciliani et al. [43]. Figure 2 presents the morphology of 146 
cultured monocytes following MACS purification technique after 1, 2 and 4 days of culture. The first 147 
steps of purification are similar for both methods. Blood is collected into tubes (or bags) containing 148 
anticoagulant and processed within 1 hour of collection. Blood is centrifuged at 1260 × g for 30 min 149 
at RT to obtain the buffy coat. Mononuclear cells are recovered after dilution of the buffy coat 1:2.5 150 
(v/v) in PBS/2mM EDTA, and 30 ml of this solution is overlaid on 15 ml Ficoll 1077 (Amersham 151 
Biosciences) and centrifuged for 30 min at 1500 × g at 4 °C. Mononuclear cells (i.e. monocytes and 152 
lymphocytes) are collected from the interface, also called mononuclear ring. The cells are 153 
resuspended in 50 ml PBS/2 mM EDTA and centrifuged for 7 min at 400 × g at 4 °C to remove 154 
platelets. To avoid non-specific activation of monocytes, it is pivotal to remove as many platelets as 155 
possible from the mononuclear cell fraction by performing second centrifugation in a 4% to 20% 156 
sucrose gradient layered over Ficoll-Paque PLUS (Sigma-Aldrich, USA). This procedure will 157 
effectively remove any platelet contamination [45,46]. Alternatively, consecutive centrifugations at 158 
low speed (400 x g for bovine monocytes), considerably reduces the number of platelets, that remains 159 
in the supernatant [43]. Table 3 summarizes the two protocols. 160 
 161 
Table 3.  162 
Purification methods for bovine monocytes * 163 
Methods Protocol 
Adherence  
A. Polystyrene surfaces 
1. Isolated PBMCs are cultured in 75 cm2 polystyrene culture flasks and 
incubated for 2 h at 38°C. 
2. No-adherent cells are removed by pipetting out the supernatant and rinsing the 
flask with warm medium (38°C). 
3. Adherent cells (monocytes) are detached by incubating them with Hank’s 
Balanced Salt Solution (HBSS) without Ca2+ and Mg2+, containing a mixture 
of 0.5 mg/mL Trypsin + 0.6 mM EDTA for 10 min at 23°C. 
4. Cells are pelleted and washed (10 min 180 x g, 4°C) with unsupplemented 
RPMI 1640 medium, and finally resuspended in the culture medium. 
5. After detaching monocytes from polystyrene flasks, to avoid monocytes loss 
by the binding to polystyrene, all procedures should be carried out at 4°C in 
polycarbonate conical tubes. 
B. Plasma coated gelatin surfaces  
1. PBMCs are cultured in 75 cm2 plasma coated gelatin (2%) culture flasks and 
incubated for 1 h at 38°C. 
2. No-adherent cells are aspirated, and the flask rinsed with culture medium 
(38°C). 
3. Adherent cells are detached by incubating the cells with HBSS without Ca2+ 
and Mg2+, containing 10 mM EDTA for 5 min at 23°C. 
4. Flasks are gently shaken, and cells recover with pipette and pelleted. 
5. Cells are washed and resuspended in culture medium at 4°C. 
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Sorting  
1. Monocytes are isolated from PBMCs with magnetic-activated cellular sorting 
technique, using a monocyte-specific monoclonal antibody (CD14+). 
2. PBMCs are incubated with anti-human CD14 labelled superparamagnetic 
beads (Miltenyi-Biotech) for 15 min at 4°C. 
3. Cells are separated through magnetic separation using Macs column 
(Miltenyi-Biotech), by first eluting the cells not bound to the column (CD14-) 
and then CD14+ cells by removing the column from the magnet. 
4. The purity of sorted cells is evaluated by flow cytometry.  
 164 
The aforementioned techniques have both advantages and disadvantages that must be considered 165 
when choosing the adequate isolation method according to each experimental requirement. MACS 166 
technique is based on the immunomagnetic separation of the cells, which allows the specific isolation 167 
of a subset of monocytes of interest (e.g., CD14+ fraction) with higher purity (> 98%) [43] than with 168 
the adherence based method [44]. Such specific marker separation is not possible when working on 169 
the isolation of monocytes by adherence from PMBC, where the authors often report the cells only 170 
as adherent (monocytes) and non-adherent (lymphocytes) [42]. Despite its advantages, this immune-171 
based method also presents some disadvantages such as higher costs and the unavailability of 172 
antibodies used for the separation of monocytes of other species than humans. This issue can be 173 
addressed by purifying cells with the adherence-based method. Finally, the latter method is also 174 
cheaper and simpler, as no complex equipment is needed. The main disadvantage of the adherence 175 
method is the potential presence of other cellular population, such as eosinophils. When blood is 176 
collected from animals with a high concentration of eosinophils, the first step of purification, e.g. 177 
centrifugation over Ficoll layer, cannot entirely remove eosinophils, which in turn can contaminate 178 
monocyte population.  179 
Once purified, population purity is assessed through flow-cytometric techniques.  180 
Briefly, a total of 100 μL of cell suspensions are labelled with FITC-anti-CD14 antibody (clone 181 
TÜK4) and incubated in the dark for 15 minutes. Cells are washed twice and resuspended in PBS for 182 
flow cytometry. Fig. 3 shows representative flow cytometry dot plots of CD14+ cells before and after 183 
MACS purification. The recovery of cells from either method yields an amount of homogenous 184 
monocyte population ranging from 8 to 10 millions of cells, starting from an initial blood volume of 185 
200 mL.  186 
Flow cytometric analysis shows that after MACS sorting, an enrichment of CD14+ monocytes 187 
population > of 95% is obtained. 188 
 189 
3. Monocyte apoptosis, pyroptosis and necrosis (necroptosis)  190 
 191 
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In multicellular organisms, a balance between cell proliferation and cell death is maintained to assure 192 
homeostasis [47]. Cells that are useless or superfluous, aged, damaged, and/or potentially harmful are 193 
selectively eliminated using genetically encoded mechanisms  [48]. Up to now several types of cell 194 
death have been described: apoptosis, necrosis, both accidental and programmed (necroptosis), 195 
pyroptosis, cell death associated with autophagy, ferroptosis, netosis, among others [49]. However, 196 
apoptosis and necrosis are the best-characterized cell death ways so far. A comprehensive list of 197 
different cell death mechanisms has been recently published by the Nomenclature Committee on Cell 198 
Death [48]. 199 
Apoptosis is an ATP-dependent type of programmed cell death, generally characterized by distinctive 200 
morphological and biochemical changes. The morphological features of apoptosis include reduction 201 
of cellular volume, condensation of the chromatin, nucleus fragmentation, plasma membrane 202 
blebbing, maintenance of plasma membrane integrity until late stages and formation of apoptotic 203 
bodies followed by dead cells phagocytosis [50]. Cells undergoing apoptosis also show biochemical 204 
changes such as externalization of phosphatidylserine on the outer plasma membrane [51], the release 205 
of mitochondrial intermembrane space proteins (Cytochrome C, Smac/DIABLO) [52], DNA 206 
fragmentation and caspase-dependent activation [53]. Several of these features were exploited to 207 
measure apoptosis rate. Apoptosis is generally not associated with inflammation, due to the absence 208 
of cells’ contents release, resulting in cell clearance from the body with minimal damage to the 209 
surrounding tissues [54].  210 
Understanding the monocyte cell death mechanism(s) is important, as the way of cell death (necrosis 211 
vs. apoptosis vs. pyroptosis) can influence the pro- and anti-inflammatory responses [55] and 212 
therefore interfere with the proper resolution of inflammation, or the clearance of the inflammatory 213 
focus from the pathogens, or cancer development [56]. Moreover, apoptosis rate is critical for normal 214 
cell turnover and proper development and functioning of the immune system. Indeed, apoptosis 215 
provides a way to control the activity of blood monocytes, by increasing or reducing their abundance 216 
in the inflammatory environment. 217 
In contrast, necrosis is generally described as an “accidental or uncontrolled” way of cell death caused 218 
by extreme physical or chemical stress [57]. The rapid cytoplasmic granulation/vacuolization, cellular 219 
and organelles’ swelling in necrotic cells, results in plasma membrane rupture, organelle breakdown, 220 
intracellular content spillage, inflammation and surrounding tissue damage [47,54]. Nevertheless, it 221 
is now known that necrosis can also occur as a caspase-independent form of regulated cell death, also 222 
known as necroptosis, following many defined steps and signalling events, just like apoptosis [57].  223 
Necrosis is the term currently used for nonapoptotic death and has been characterized as passive, 224 
accidental cell death resulting from environmental perturbations with the uncontrolled release of 225 
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inflammatory cellular contents. The presence of necrosis provides evidence that a cell has died, but 226 
not necessarily how the death occurred. The necroptosis is defined as the caspase-independent, 227 
regulated cell death (RCD). In the recent years, research studies concerning caspase-independent, 228 
non-apoptotic forms of programmed cell death (PCD) have enabled the identification of backup 229 
mechanisms to allow the cells to undergo suicide or RCD under conditions where the caspase 230 
machinery is defective or inhibited [58]. 231 
Another type of regulated necrosis so far described and measured in monocytes and macrophages is 232 
pyroptosis. Pyroptosis occurs in response to microbial products or other intracellular perturbations, 233 
which cause the production of proinflammatory cytokines like IL-1, leading to cell swelling and 234 
death [57]. Being initially thought to occur only in macrophages and leukocytes during inflammatory 235 
conditions, pyroptosis has now been observed in several other cell types, including fibroblasts and 236 
endothelial cells [59]. Pyroptosis is generally characterized morphologically by membrane pore 237 
formation, cell swelling, membrane disruption and DNA damage, whereas biochemically by an 238 
inflammatory caspase activation (non-apoptotic caspase-1), that mediates cytokine maturation 239 
[57,60]. The identification of distinctive and specific markers in all of these three types of cell death 240 
has long been used for their in vitro and in vivo discrimination in many cell types including monocytes 241 
and macrophages. 242 
 243 
3.1. In vitro assays measuring monocytes/macrophages apoptosis  244 
 245 
In vitro apoptosis can be determined through several methods: by characterizing cell morphology 246 
through microscopy or by measuring biochemical cell death features, like caspase activation, that is 247 
activated uniquely during the apoptosis [47]. Methods relying on flow cytometry have also been 248 
widely applied in human and murine research to distinguish apoptosis from necrosis [61]. 249 
Specifically, the measurement of the activity of the two main effectors enzymes in apoptosis, namely 250 
caspase-3 and -7, has been already reported and validated in bovine monocytes (CD14+) [20,32]. In 251 
these studies, the activation of the two enzymes was measured through fluorometry, using a detection 252 
assay that contains aa pro-fluorescent substrate the rhodamine 110, bis-(N-CBZ-L-aspartyl-L-gluta-253 
myl-L-valyl-L-aspartic acid amide - Z-DEVD-R110) and a cell lysis buffer that supports optimal 254 
caspase activity. The assay is adapted to small well formats, such as 96 or 384-well plates. Depending 255 
on the selected format, between 5x104 cells for 384-well up to 1x105 cells for 96-well plates are seeded 256 
in final volumes of 25 𝜇L to 50 𝜇L, respectively [43,63]. In a second step, an equal volume of Apo-257 
ONETM Homogeneous Caspase 3/7 Reagent (Promega, USA), containing the pro-fluorescent 258 
substrate and previously diluted 1:100 in the reaction buffer, is added to each well. Plates are then 259 
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incubated in a plate shaker at 300 rpm for 1 h at room temperature. According to the manufacturer’s 260 
instructions, incubation times should be optimized for each model as minimal apoptotic induction 261 
and low cell numbers may require extended incubation periods. Finally, upon cleavage of the DEVD 262 
peptides by caspase-3 and -7 activities, the fluorescent compound rhodamine 110 is released and 263 
fluorescence intensity can be measured using a fluorescence plate reader (excitation at 485 nm, 264 
emission at 530 nm).  265 
Caspase activity can also be measured through colourimetric assays. For example, a caspase 266 
colourimetric protease assay (Aportaget; Invitrogen, Canada) kit has been used to determine the 267 
activity of caspases-3, -6, and -9 in monocytes infected with Mycobacterium bovis [64]. This assay 268 
can be carried out by lysing a pellet of infected monocytes containing 5 × 106 cells with 50 μL of 269 
chilled cell lysis buffer provided by the kit and incubated for 10 min, before centrifuging them at 270 
10,000 × g. The supernatant containing the cytosolic fraction is transferred to a fresh tube and the 271 
protein concentration is quantified. After having adjusted the cytosolic fraction concentration (200 272 
μg/mL) in the cell lysis buffer provided in the kit, 50 μL of it are transferred to 96-well round-plates 273 
and 50 μL of 2×kit reaction buffer, containing 10 mM of dithiothreitol (DTT) and 200 μM the 274 
respective substrate for the caspases, is added in a volume of 5 μL. Finally, samples are incubated at 275 
37°C for 2 h in the dark and then read at 405 nm with a 490-nm reference filter in a microplate reader. 276 
Bovine monocyte-derived macrophages apoptosis has also been detected trough fluorometric analysis 277 
of caspase-3 activity [63] and relative quantification of histone-complexed DNA fragments, that are 278 
often out of the cytoplasm of cells undergoing apoptosis [65], using Cell Death Detection 279 
ELISAPLUS kit (Roche, Switzerland) [66]. Because histone-complexed DNA release is not an 280 
exclusive phenomenon of apoptosis but also can occur in necrotic cells, using complementary assays 281 
is preferred [67].  282 
 283 
3.2. In vitro assays measuring monocytes necrosis  284 
 285 
The permeabilization of cells’ plasma membranes and its consequent release of cellular content are 286 
some of the hallmarks of necrosis. The release of lactate dehydrogenase (LDH), an ubiquitous 287 
cytosolic enzyme, into the supernatant after membrane integrity loss has long been measured to detect 288 
necrosis in multiple cell types by spectrophotometry, including bovine monocyte-derived 289 
macrophages [63,66,68]. Specifically, in the study of Denis and coworkers [66], a commercially 290 
available kit (CytoTox 96®, Promega, USA) was used to measure the LDH released to the 291 
supernatants by a 30-minute coupled enzymatic assay that leads to the conversion of a tetrazolium 292 
salt (iodonitro-tetrazolium violet; INT) into a red formazan product, which is proportional to the 293 
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amount of LDH present and thus to the number of damaged cells. Besides INT, the kit reagents also 294 
contain the substrates lactate, NAD+ and diaphorase to complete the reaction, as the first two are 295 
needed to produced reduced nicotinamide adenine dinucleotide (NADH) that is later used to convert 296 
INT into the coloured product in the presence of diaphorase [68]. According to the manufacturer 297 
instructions, cells are first seeded in 96- or 384-well plates and treated with the desired experimental 298 
design. Afterwards, the supernatants are transferred to a fresh plate (50 μL for a 96-well and 12.5 μL 299 
for a 384-well plate) and an equal volume of CytoTox 96® Reagent is added. Plates are protected 300 
from light and incubated for 30 min at room temperature. Finally, 50 or 12.5 μL of Stop Solution are 301 
added and absorbance measured 490nm or 492nm [66]. Other techniques based on differential uptake 302 
of DNA binding dyes, like propidium iodide (PI), that do not enter living cells, have also been used 303 
for determination of bovine necrotic neutrophils [69], blood monocytes and macrophages (CD14+) 304 
isolated from the mammary gland through flow cytometry [70].  305 
 306 
3.3.In vitro assays measuring monocytes pyroptosis  307 
 308 
The discrimination between necrosis and pyroptosis can be a challenging task as many of the 309 
hallmarks for regulated necrosis such as plasma membrane rupture, cytoplasmic 310 
granulation/vacuolization and cellular/organelle swelling are also shared by pyroptosis [71]. The 311 
measurement of LDH release has also been implemented for pyroptosis determination of human and 312 
murine bone marrow-derived macrophages, as it is a simple and cost-effective technique [62,72]. 313 
DiPeso and coworkers monitored the cells’ LDH secretion, as previously described [59,73], after 314 
reacting with a pyroptosis inducer called RodTox that activates the NAIP2/NLRC4 inflammasome, 315 
leading to caspase-1 activation and pyroptosis. Additionally, a more specific way to measure 316 
pyroptotic death of individual cells in vitro can be carried out through the measurement of caspase-1 317 
activation and inflammasome formation (NLRP3) by both fluorescence or confocal microscopy [74]. 318 
Cells are labelled with the caspase-1 activity probe FAM-YVAD-FMK that specifically binds to the 319 
caspase-1 family proteases, and with antibodies against inflammasome components such as the 320 
adaptor protein ASC that recruits pro-caspase-1. For that, murine marrow-derived macrophages are 321 
first seeded in 96-well plates and stimulated with 100 ng/mL of LPS for 3 h at 37°C to prime Toll-322 
Like Receptor 4 (TLR4), the first step needed for NLRP3 activation. Afterwards, the medium is 323 
removed, and cells are stimulated with fresh DMEM medium-containing 5 μM nigericin to induce 324 
the second step for the activation of the NLRP3 inflammasome, and 5 mM glycine to reduce the cell 325 
lysis caused during caspase-1 activation. Cells are then incubated for 60 min at 37°C and 5% CO2, 326 
and during the last 45 min incubated as well with 30x of the FAM-YVAD-FMK probe, which is 327 
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prepared according to the manufacturer's instructions. After incubation, the medium is removed and 328 
the cells are washed three times for 5 min with cold PBS. Finally, the cells are fixed and stained with 329 
a fluorescent nucleic acid stain to label the nuclei and mounted for a correct visualization by confocal 330 
microscopy, with an excitation/emission of 492/520nm for the FAM-YVAD-FMK probe. For the 331 
antibody staining of the inflammasome component (ASC), after seeding, priming and exposing the 332 
cells to nigericin, the cells are washed with cold PBS, fixed and permeabilized on ice and in dark for 333 
30 min. Macrophages are washed with the washing buffer and the primary antibody anti-ASC (1:500) 334 
is added and cells are incubated for 1 h on ice. The cells are again washed and the secondary antibody 335 
(fluorescent dye conjugated goat anti-mouse; 1:500) is added for another 1 h on ice. During the last 336 
5 min of this incubation, the dye to stain the cells’ nuclei is also added. Finally, cells are washed and 337 
prepared for confocal analysis with an excitation/emission for the secondary antibody of 555/580 nm. 338 
According to Hartigh and Fink, to successfully determine pyroptotic cells the nuclear morphology 339 
should be considered, as cells with active caspase-1 possess a rounded and condensed nuclei without 340 
visible nucleoli, often present in cells without caspase-1 activation [74]. 341 
Even though the previously described techniques have been carried out mostly in human and murine 342 
macrophage models, the same ones can be applied to bovine monocytes/macrophages’ pyroptosis 343 
determination, although they have been not tested so far.  344 
 345 
3.4. Flow cytometric assays to evaluate apoptosis, necrosis (necroptosis) and pyroptosis  346 
 347 
Determining the number of dead cells during a flow cytometry study is a prerequisite to obtain reliable 348 
data, given that dead cells can bind in a non-specific way to many reagents. Therefore, removing dead 349 
cells from flow cytometry data is a prerequisite and a critical step to ensure accurate results and 350 
analysis [55]. A widely used flow cytometric assay to define cell viability is based on the reaction of 351 
a fluorescent dye, such for example propidium iodide (PI), with cellular amines. This die cannot 352 
penetrate live cell membranes: consequently, only cell surface proteins are available to react with the 353 
dye, resulting in dim staining. The reactive dye can permeate the damaged membranes of dead cells 354 
and stain both the interior and exteriors amines, resulting in more intense staining [72]. In normal 355 
living cells, the phosphatidylserine (PS) is located at the side of the cytoplasmic surface of the cell 356 
membrane. However, during early apoptosis, PS is translocated from the cytosolic side of the intact 357 
plasma membrane to the extracellular surface. Early apoptotic cells cannot, therefore, be reliably 358 
identified using approaches that are based on membrane permeability. Annexin V is a protein with 359 
high affinity, specificity, and sensitivity for PS. Thus, the binding of annexin V to cells can be used 360 
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as a marker of early apoptosis [75] and provides the most commonly used approach for determining 361 
apoptosis [55].  362 
A typical experimental protocol to detect apoptosis is the following: 100 L of cells suspension 363 
(1x106 cells/mL) in 1X annexin-binding buffer are incubated with 5 L of fluorescein isothiocyanate 364 
(FITC)  annexin V and 1 L of PC5.5-PI (100g/mL) in the dark at room temperature for 15 min. 365 
Finally, 400 L of the annexin V binding buffer is added and the cells are analyzed by flow cytometry. 366 
The binding of annexin V to PS is reversible, and so samples must be analyzed as soon as possible 367 
and no later than 1 h after labelling. Fig. 4 illustrates the typical aspect of a dot plot flow cytometry 368 
analysis using annexin V/PI double staining to determine in the percentages of live, apoptotic and 369 
necrotic bovine peripheral blood lymphocytes and monocytes. Beside annexin V staining, the 370 
measurement of caspases activity is also widely used to determine the apoptosis rate. Caspases are a 371 
family of cysteine proteases that plays a key role in apoptosis and inflammation. These enzymes are 372 
present in healthy cells as inactive zymogens, but when stimulated they undergo autolytic cleavage 373 
to become fully active. Consequently, many of the cleaved fragments remain intact during apoptosis 374 
and can be detected using specific antibodies. These antibodies can be used to specifically label cells 375 
in which caspase cleavage has occurred, allowing to quantify these cells by flow cytometry. Several 376 
antibodies that specifically recognize caspase-cleaved fragments have been generated, including 377 
antibodies that recognize the cleaved form of caspase-3, a key protease activated during the early 378 
stage of apoptosis [76].  379 
For flow cytometric detection of active caspase3, 1x106 cells are washed with PBS and then 380 
resuspended with 100 L of fixation/permeabilization buffer (Cytofix/CytopermTM, BD Biosciences, 381 
USA)) for 20 min at room temperature. In the following step, cells are washed twice with 600 L of 382 
erm/WashTM (BD Biosciences, USA) buffer and stained with the PE- rabbit anti-active caspase-3 383 
antibody (clone C92-605) for 40 min at 4°C. Cells are then washed and resuspended in Perm/WashTM 384 
buffer for flow cytometric analysis. 385 
 Both pyroptosis and apoptosis are programmed cell death mechanisms but are dependent on different 386 
caspases. Pyroptosis is triggered by caspase-1 after its activation by various inflammasomes and 387 
results in lysis of the affected cell. Pyroptotic cell death could be assessed in PBMC and monocytes 388 
by flow cytometry by measuring the double-positive staining of activated caspase-1 and PI [77]. 389 
Furthermore, Hussen and coworkers [20], analyzed the inflammasome activation in bovine 390 
monocytes through the evaluation of caspase-1 activation. Authors used the FLICACaspase-1 391 
detection KIT (Thermo-Fisher, USA), a fluorescent inhibitor of active caspase-1 (FAM-YVAD-392 
FMK), which binds activated caspase-1. First, bovine PBMC or purified monocytes (1 x106) are 393 
stimulated for 2 h with LPS (100 ng/mL). Then ATP (2 mmol/L) is added to the cell culture for a 394 
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further 30 min. After stimulation, cells are detached from the plates by Accutase™ (Sigma-Aldrich, 395 
USA) treatment (incubation for 15 min at 37°C and 5% CO2). Cells are then suspended in 300 L 396 
RPMI medium and 10 L of the 30X FLICA solution is added. After the incubation (1 h at 37°C and 397 
5% CO2) with FLICA, cells were washed two times with the FLICA buffer and suspended in 200 L 398 
of the same buffer. For flow cytometric analysis PI (2 g/mL final concentration) is added to exclude 399 
dead cells. 400 
 401 
4. Monocyte and macrophage chemotaxis  402 
 403 
Chemotaxis is the ability of cells to migrate in response to a chemical signal or chemoattractant 404 
gradient concentration. It is a crucial function of leukocytes, including monocytes, as they fulfil their 405 
defensive functions by migrating from blood to affected tissues, where they produce pro-406 
inflammatory cytokines and reactive oxygen species (ROS) and eventually phagocyte and destroy the 407 
invading pathogens [78].  408 
Monocyte chemotaxis is determined by using the Boyden chamber assay, composed of an upper and 409 
a lower compartment separated by a porous membrane (Fig. 5a). This assay consists mainly of 410 
monitoring the migration of the cells through a microporous membrane. In general, the cells are 411 
seeded in the medium-filled upper compartment and are allowed to migrate through the pores of the 412 
membrane, towards the medium-filled lower compartment where chemoattractants are present [79]. 413 
To assure the correct migration of the cells through the membrane, this one must be selected with the 414 
appropriate pore size for the cells of interest. Human monocyte chemotaxis is usually triggered by N-415 
Formylmethionine-leucyl-phenylalanine (N-fLMP), a formylated peptide derived from bacteria [80], 416 
which specifically reacts with Formyl Peptide Receptors [81]. Bovine cells do not have N-fLMP 417 
receptors [82,83]. In this species, therefore, chemotaxis should be triggered with other 418 
chemoattractants, including, such as, for example, zymosan activated serum (ZAS) [84]. The in vitro 419 
chemotactic capacity of bovine monocytes has been determined using this principle with a modified 420 
Boyden chamber [84]. In this study, bovine monocyte migration was measured using a 48-well 421 
microchamber, where the chemoattractant ZAS was added in the lower part of the chamber. A PVP-422 
free polycarbonate filter (5 μm pore size) was layered onto the lower wells and covered with a silicone 423 
gasket and finally with the top plate above. In the upper wells, 1.5 x 106 cells/mL were seeded (50 μL 424 
final volume) and the chamber was incubated at 37°C in 5% CO2 for 105 min. The microchamber 425 
was disassembled and the filters were removed carefully, the non-migrated cells on the upper part of 426 
the filter were removed by scraping and the migrated cells found in the lower part of it were stained 427 
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with Romanowsky type stains including May‐Grünwald‐Giemsa and Wright's stains. Finally, cells 428 
were counted in different high-power oil-immersion fields.  429 
Modified Boyden chamber devices, allowing a more convenient and user-friendly methodology to 430 
carry out the cell migration studies, are commercially available. Such is the case of the transwell 431 
migration plates (Fig. 5b), that contain easy-to-use permeable cell culture membrane inserts of 432 
different pore sizes that can be removed from the plates when needed to stain and count the cells that 433 
have migrated through the membrane. The transwell migration assay has been described to assess the 434 
chemotactic activity of human blood monocytes and the human monocyte cell line THP-1 [85] and 435 
can be also used for bovine studies. In this study, 1x105 of THP-1 and blood monocytes were seeded 436 
in the upper chamber of a 24-well transwell migration plate in a final volume of 125 μL of serum-437 
free media. The monocyte chemoattractant protein-1 (MCP-1) and “platelet-releasate”, which is the 438 
content released by secretory granules of activated platelets, were added as chemoattractants to the 439 
lower chamber in a final volume of 1 mL and plates incubated for 2 h at 37°C. After incubation, the 440 
upper chambers were removed and placed into 2.5% glyceraldehyde for 15 min to fix the migrated 441 
cells found on the underside of the membrane. The membranes were washed with PBS, and the upper 442 
chambers were stained with 0.1% of crystal-violet for 45 min. Finally, cells were washed twice with 443 
PBS and cells in ten 40x fields were counted using light microscopy. 444 
Chemotaxis of monocyte-derived macrophages has been measured as well [86], using the same 445 
technique, e.g. the migration through Boyden chamber, previously described.  446 
The Boyden chamber technique has been modified over the years to allow the quantification of total 447 
migrating leukocytes concurrently with the determination of their phenotype to associate specific 448 
inflammatory responses with distinct leukocyte subsets. Gomez-Lopez and coworkers [87] validated 449 
in humans a combined Boyden-flow cytometry chemotaxis assay (CBFCA), that allows the accurate 450 
quantification and recovery of the migrating leukocytes for subsequent phenotyping and 451 
characterization in a single assay, facilitating the understanding of leukocyte trafficking during the 452 
inflammatory response. The combined chemotaxis assay is performed under the same conditions 453 
described for the classic method, but only the polycarbonate membrane was used. Following 454 
incubation, the leukocyte suspension in the lower well is recovered and cells counted by flow 455 
cytometry. To our knowledge, the CBFCA assay has not yet been applied to study chemotaxis of 456 
bovine monocytes. 457 
 458 
5. Monocyte/macrophages phagocytosis and killing  459 
 460 
16 
 
Phagocytosis and respiratory burst are two of the most important functions for 461 
monocytes/macrophages and polymorphonuclear cells and are essential for both the elimination of 462 
invading microorganisms and the presentation of antigens to T-cells. Phagocytosis is a process in 463 
which target particles are engulfed and taken up by other cells, crucial to the innate immune response 464 
and consequently regulating the adaptive immune response [88]. Phagocytic affinity is related to 465 
particular marker expression patterns, directed by a complex range of cell surface receptors, and may 466 
also change in different populations of monocytes [88]. Bovine monocytes mediate the inflammatory 467 
response activated in phagocytosis and killing capability, which leads to different abilities to 468 
phagocytose bacteria between the different monocyte’s subsets – cM are the ones with the highest 469 
phagocytosis, followed by intM and ncM with the lowest ability [18]. The phagocytosis ability of 470 
monocytes can also relate to other factors such as age, breed, nutrition and the clinical status of the 471 
animal [89–91]. Lymphocytes in neonatal calves have poorer phagocytosis ability but counterbalance 472 
with higher absolute numbers, in contrast to monocytes of neonatal calves that showed a higher 473 
bacterial uptake than 3-9 week old calves, suggesting that the monocytes contribute to the 474 
compensation of impaired earlier innate immune defence in infancy [92]. A similar mechanism seems 475 
to take place in the mammary gland, where a greater number of viable macrophages may partially 476 
compensate for the functional deficit in polymorphonuclear cells in cows with high somatic cell 477 
counts [93]. 478 
The in vitro phagocytosis assay of bovine monocytes can be performed by co-culturing the cells with 479 
opsonised fluorescein-labelled bacteria and then incubating them at 37oC in a humidified atmosphere 480 
of 5% CO2 for 1 h. The cells are washed twice with sterile HBSS and then incubated with trypan blue 481 
to quench non-internalised fluorescent bacteria, and after two subsequential washes with HBSS, the 482 
intensity of the fluorescence, which can be correlated with the phagocytic ability, can be measured 483 
[44]. Improved results have been achieved in vitro in the study of monocyte-derived macrophages 484 
phagocytosis when opsonizing bacteria with naive-autologous sera than bacteria opsonized with fetal 485 
bovine serum [94]. 486 
Phagocytosis assays of monocyte-derived macrophages can also be performed by co-incubating the 487 
cells with opsonised bacteria in a ratio of one bacterium to one macrophage, in a water bath at 37o C 488 
under continuous rotation. The suspension is removed and added to ice-cold gelatine-Hanks’ salt 489 
solution to stop phagocytosis, and the macrophages are centrifuged (110 x g for 4 min) to remove the 490 
non-ingested bacteria, that remain in suspension in the supernatant fluid. The supernatant is then 491 
seeded on tryptic soy agar plates, in dilutions between 10 and 100 colony counts, incubated in 8% 492 
CO2 at 37
oC for 72 hours. The results are expressed as the percentage of survival of non-493 
phagocytized/non-cell-associated bacteria based on the formula [94]: 494 
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 495 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 =
𝐶𝐹𝑈 𝑜𝑓 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 𝑎𝑓𝑡𝑒𝑟 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑖𝑛𝑔 𝑓𝑜𝑟 120 𝑚𝑖𝑛
𝐶𝐹𝑈 𝑜𝑓 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 𝑎𝑡 𝑡𝑖𝑚𝑒 0
𝑥 100 496 
 497 
The monocyte’s and macrophage's ability to bind, internalize and kill bacteria occur as independent 498 
and sequential steps, and, as a result, a phagocyte may be able to ingest a pathogen and yet not manage 499 
to kill it. Thus, the phagocytosing and killing capabilities of monocytes and macrophages should be 500 
measured by separate assays [95]. The in vitro intracellular bacterial killing assay is performed by 501 
co-incubating bovine monocytes (5 x 105 cells) with opsonised bacteria (E. coli) for 60 min. The 502 
unbound bacteria are removed, by centrifuging them at 110 x g for 5 min, and the cell pellet is 503 
resuspended in HBSS with 100 µg/mL gentamicin, to kill any remaining extracellular bacteria, and 504 
then incubated for 1 h at 37o C. Cells are washed with warm HBSS and then centrifuged again at 110 505 
x g for 5 min to remove the gentamicin. The cells are then lysed by incubation on ice with 0.5% Triton 506 
X-100 for 10 min and the surviving bacteria are seeded on MacConkey agar plates for CFU counting 507 
[44].  508 
Flow cytometric assays have been developed to quantify phagocytosis and respiratory burst in whole 509 
blood, as well as isolated cells from blood, tissue or secretions [96,97]. Hussen and coworkers [98] 510 
reported a flow cytometric assay to evaluate phagocytosis capacity of bovine monocytes. FITC-511 
conjugated and heat-killed S. aureus or E. coli were opsonized with heterologous bovine serum 512 
(diluted 1:10 with PBS) for 45 minutes at 37°C. MACS-separated bovine monocyte subsets were 513 
incubated for 24 h (37°C, 5% CO2) in RPMI medium. After this resting period, cells were incubated 514 
with opsonized bacteria (50 bacteria/cell) for 40 minutes (37°C, 5% CO2). Control samples were 515 
incubated without bacteria. After incubation, samples were analyzed using flow-cytometry after the 516 
addition of propidium iodide (2 mg/mL final concentration) to exclude dead cells. Phagocytic activity 517 
of different monocyte subsets is defined as the percentage of green fluorescing cells among viable 518 
cells. 519 
 520 
6. Monocyte/macrophages ROS production  521 
 522 
Generation of reactive oxygen species (ROS) is a critical factor in the antimicrobial activities of 523 
monocytes, though it may also lead to cellular cytotoxicity and/or tissue damage. The intracellular 524 
presence of ROS can result in damage to the intracellular constituents and oxidative stress, which 525 
may have consequential alterations in monocyte’s function [88]. As other functional abilities, ROS 526 
production differ between different monocyte populations – bovine intM is reported to present the 527 
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strongest production between the subsets [18] – and virulent pathogens of cattle, such as N. caninum, 528 
may also regulate ROS production of infected macrophages [88]. 529 
The production of oxidative burst activity of bovine monocytes can be measured in vitro using a 530 
cytochrome C reduction assay, as similarly used in bovine and caprine neutrophils and goat 531 
monocytes [99,100]. The measurement of cytochrome C reduction is commonly used for the 532 
measurement of extracellular superoxide anion [101] and demonstrated a dose-dependent specificity 533 
in detecting extracellular superoxide production in bovine neutrophils [99]. The extracellular ROS 534 
production is measured by mixing 2 x 105 monocytes in RPMI-1640 medium (adjusted final volume 535 
on wells of 200 L) and cytochrome C (1 mM). Parallel studies to assess the ROS production after 536 
inducing a pro-inflammatory challenge to the cells, by adding phorbol 12-myristate-13-acetate 537 
(PMA), can also be performed. PMA (2.5 g/mL final concentration) and cytochrome C (1 mM) are 538 
added to the cells and the absorbance is measured immediately with a plate reader every 30 min for 539 
2 h at a wavelength of 550 nm. Background values are measured from wells with cytochrome C 540 
diluted in RPMI-1640 and subtracted from all values [102]. Analysis of ROS generation via 541 
cytochrome C reduction assay has been used in bovine monocytes and alveolar macrophages (AM), 542 
revealing that monocytes appear to be less responsive in ROS formation than AM, likely for being 543 
more immature and thus possessing less cytoplasmic organelles enabling metabolic processes [103]. 544 
Production of ROS reduces substrates such as dichloro‐dihydro‐fluorescein‐diacetate (DCHF) or 545 
dihydro‐rhodamine 123 (DHR 123) that become fluorescent and can be quantified by flow cytometry. 546 
Hussen and Coworkers [98] reported a typical flow cytometric analysis of ROS generation on bovine 547 
monocyte. The analysis is performed after stimulation of cells with PMA (50 nmol/L) or heat-killed 548 
and serum opsonized E. coli (50 bacteria/cell) for 15 min (37°C, 5% CO2) in the presence of the 549 
fluorogenic substrate DHR 123 (750 ng/mL). ROS generation is calculated as Mean Fluorescence 550 
Intensity (MFI) of gated monocyte region after subtracting the MFI of non-stimulated cells. 551 
 552 
7. Monocyte/macrophages production of cytokines  553 
 554 
Cytokines are important chemical messengers produced by both innate and adaptive immune cells, 555 
that allow the communication between both types of immunity and within the adaptive immune 556 
system [104]. Specifically, monocytes and macrophages play a critical role in immune regulation by 557 
producing a wide range of pro and anti-inflammatory cytokines like TNF-𝛼, IL-1, IL-6, IL-8, IL-558 
10, IL-12, and TGF-𝛽1 [105]. At the same time, these cytokines modulate their functions by 559 
stimulating or inhibiting their microbial activities in an autocrine and paracrine manner [106] and are 560 
also involved in cell migration, activation, proliferation and antibodies’ production. Moreover, 561 
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monocytes and macrophages can be further classified into different subsets according to the cytokine 562 
profile they produce [107]. Therefore, the measurement of monocyte and macrophage cytokine 563 
production is a highly useful approach for phenotyping and characterizing their functionality.  564 
Bovine monocytes’ cytokine production can be measured mainly by two approaches: detection of 565 
secreted cytokines at the protein level through enzyme-linked immunoabsorbent assays (ELISAs) 566 
[64] or by measuring cytokines’ mRNA abundance by real-time quantitative PCR (q-PCR) 567 
[16,21,62,108]. 568 
Several commercially available ELISA kits have been used for the quantification of bovine cytokines, 569 
including IFN-γ [109,110], TNF-α [111], IL-1β [112] and IL-4 [111]. However, the quantification of 570 
secreted cytokines in monocytes/macrophages can be performed by other methods. Recently, type 1 571 
IFN was measured in ovine alveolar macrophages’ supernatant by using an IFN bioassay [113]. An 572 
IFN bioassay is a method to quantify IFN biological activity units, meaning it measures the actual 573 
biological power of an IFN preparation in a specific cell line or biological system [114]. It is well 574 
known that IFNs types’ cytokines induce a potent antiviral activity in vertebrate cells [115]. 575 
Therefore, this method mainly relies on type 1 IFN antiviral properties and determines the amount of 576 
IFN in a solution- usually secreted by virus-infected monocytes/macrophages- according to its ability 577 
to neutralize viral replication and protect the infected cells in culture from cytopathic effects. One of 578 
the most common IFN bioassays is based on the quantification of the fluorescence intensity of viral-579 
encoded reporter proteins, like green fluorescent protein (GFP), during the virus replication in cell 580 
culture [116]. The protective effects of IFN are then quantified by measuring the fluorescence 581 
intensity and is determined by the ED50 that is the amount of IFN needed to reduce the fluorescence 582 
by 50% [114]. Briefly in ovine, the bioactivity of IFN secreted by Sendai virus-infected ovine alveolar 583 
macrophages was quantified by first serially diluting the IFN containing supernatant in DMEM 584 
medium supplemented with FBS and antibiotics. This supernatant was then added to 2 × 104 ovine 585 
fibroblasts that were seeded the day before in 96 well plates, and cells were incubated at 37 ◦C for 24 586 
h. After incubation, supernatants were removed and ovine fibroblasts were infected with 587 
Recombinant Vesicular Stomatitis virus expressing GFP (VSV-GFP) at a multiplicity of infection of 588 
0.01 and incubated at 37 ◦C. After 18 h post-infection, the green fluorescence of VSV-GFP infected 589 
cells was detected by using a plate reader with an excitation wavelength of 480 nm and emission of 590 
518 nm [113]. This method gives extra information when compared to ELISA, as by quantifying IFN 591 
with a bioassay one can measure the antiviral activity on a specific experimental condition without 592 
needing absolute numbers [114]. 593 
To measure bovine monocytes’ cytokines mRNA abundance using qPCR [62], RNA from at least 1 594 
x 106 cells/well is extracted by using guanidinium-acid-phenol extraction methods, such as TRizol™ 595 
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(Thermo-Fisher, USA) or Qiazol™ (Qiagen, Germany), or commercial kit [117]. After having 596 
assessed the quality and concentration of RNA using a NanoDrop ND-1000 UV–vis 597 
spectrophotometer, an Agilent Bioanalyzer or a Qubit fluorometer, genomic DNA is eliminated using 598 
DNase I, RNase free kit. Reverse transcription is then carried out on RNA using commercially 599 
available cDNA Synthesis kit. The cDNA is then used as a template to perform qPCR or microarray. 600 
To carry out a reliable relative quantification, at least three adequate reference genes should be 601 
identified and the geometric mean is used for normalization [118,119]. In the published MIQE 602 
(Minimum Information for publication of Quantitative real-time PCR Experiments) guidelines is 603 
indeed proposed the validation of RGs for all qPCR experiments [120]. Statistical softwares like 604 
geNormTM, NormFinder© and BestKeeper can be used to assess the appropriateness and stability of 605 
these genes [121–124]. The list of reference genes that have been used for quantitative real-time RT-606 
PCR gene expression studies in monocytes and macrophages is reported in Table 4. 607 
 608 
Table 4.  609 
Validated reference genes for monocytes and macrophages used for qPCR. 610 
Symbol Name Accession 
number 
Cell target Target 
specie 
Ref. 
HMBS 
 
B2M 
Hydroxymethyl-bilane 
synthase 
NM_013551 Macrophages Murine [121] 
-2-microglobulin  
 
NM_009735 
ACTB  
 
RPL37A 
-actin NM_001101.3 THP-1 
monocyte 
cell line 
Human [122] 
Ribosomal protein L37a NM_000998.4 
SF3A1 
 
ACTB 
 
HMBS 
Splicing factor 3 subunit 1 NM 001081510 Monocytes/ 
Other tissues 
Bovine [123] 
-actin BT030480.1 
Hydroxymethyl-bilane 
synthase 
NM 001046207.1 
H3F3A 
 
SF3A1  
 
 
YWHAZ 
H3 histone, family 3A (H3-
3B) 
NM_001014389.2 Monocytes Bovine [62] 
Splicing factor 3 subunit 1 NM 001081510 
Tyrosine 3-
monooxygenase/tryptophan 
5-monooxygenase 
activation 
protein, zeta polypeptide 
XM_025001429.1 
 611 
Additional studies have also reported the adequateness of some of the previously mentioned reference 612 
genes like YWHAZ and ACTB in different ovine tissues (brain, spleen, mesenteric lymph nodes) 613 
[125]; and of YWHAZ in goats’ frozen whole blood [126], but not specifically in 614 
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monocytes/macrophages. Remarkably, the stability of all the genes tested in different ovine tissues 615 
changed significantly within each tissue, suggesting that there is not a unique universal reference gene 616 
for all tissues or cell types and that their stability must be evaluated prior the start of each study. Such 617 
a statement can be further confirmed by the fact that in a previous study, ACTB was not an appropriate 618 
reference gene for gene expression analyses in ovine interstitial cells[127].  619 
Intracellular cytokine staining (ICS) of stimulated whole blood or isolated PBMC followed by flow 620 
cytometric analysis is a well-established method for detecting cytokines production at the single-cell 621 
level. Recent studies developed a cytokine flow cytometric assay to detect intracellular IFN-γ in cattle 622 
naturally infected with M. bovis [128]. The detection of intracellular IFN-γ may represent an 623 
important alternative approach for an improved method of detection of cattle secreting IFN-γ below 624 
levels of detection in the culture medium. 625 
It is important to consider that the analysis of intracellular targets using flow cytometry presents 626 
several technical challenges that are not generally encountered in the measurement of cell surface 627 
epitopes. In general, cells must be first fixed to preserve and maintain both the structure and location 628 
of target epitopes, then permeabilized to allow antibodies access to all cellular compartments, such 629 
as the cytoplasm. In general, cell fixation is accomplished using either crosslinking fixatives, such as 630 
formaldehyde, or low molecular weight alcohols (methanol), which generally act to coagulate 631 
proteins. However, the fixation–permeabilization and methanol treatment need to be validated for the 632 
complete set of antibody conjugates used for a new experiment [55].  633 
Short-term stimulation of PBMC (6-16 h) with antigen or peptide mixtures is required to induce 634 
cellular activation and production of cytokines. Cells can also be stimulated in 15 mL conical 635 
polypropylene tubes or plates. Secretion inhibitors such as Brefeldin A and/or Monensin are added at 636 
the time of stimulation (for peptides) or after 2 h (for proteins) to allow secreted cytokines and other 637 
proteins to be retained intracellularly. At the end of the stimulation period, cells can be held at 4–638 
18°C until ready to process. They are then co-incubated with 0.2 mg/mL of EDTA at room 639 
temperature to remove adherent cells, fixed, permeabilized and stained for intracellular determinants. 640 
In some cases, surface marker staining is carried out jointly with intracellular staining. However, most 641 
other cell-surface markers require staining before fixation, because the epitopes recognized by 642 
staining antibodies are sensitive to fixation and/or permeabilization reaction [129].  643 
 644 
8. Phenotypic characterization of monocyte subsets: the flow cytometry approach 645 
 646 
The flow cytofluorimetric approach allows the immunophenotypic characterization and absolute 647 
count of the monocyte subsets. Hussen et al. [17] demonstrated for the first time that bovine 648 
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monocytes can be distinguished in three subsets on the differential expression of CD14 and CD16. 649 
Similar to humans, bovine cM are CD14+CD16- and intM CD14+CD16+. On the contrary, ncM are 650 
CD14-CD16+. Further evidence [19,130,131] suggested that CD14 is not a useful marker for the 651 
immunophenotyping studies and cell sorting experiments of non-classical monocytes.  652 
CD172a, a member of signal regulatory protein (SIRP) family, is a marker for myeloid cells and 653 
neurons [132]. Two specific mAbs (Table 5), can be successfully used to identified bovine 654 
monocytes, granulocytes, macrophages and dendritic cells [133], suggesting their potential use as 655 
pan-monocyte markers. Interestingly, clone DH59B recognizes a conserved epitope across a wide 656 
range of other species including small ruminants [134], dog [135], water buffalo [136] and dolphins 657 
[137]. 658 
Although CD163 is a monocyte/macrophage differentiation antigen [138], and its expression in ncM 659 
is very low or absent [16,17], it is still regarded as an important functional marker. 660 
A multicolour panel designed for a proper resolution of these subsets should, therefore, contain the 661 
markers: CD14, CD16, CD163, CD172a and a fluorescent dye for dead cell exclusion. Besides, 662 
CD335 (NKp46) should also be used to exclude NK cells. In Table 5 a list of monoclonal antibodies 663 
that can be used with either direct or indirect labelling protocols using anti-mouse secondary 664 
fluorescent antibodies is reported, although labelling of monocytes is still a hot topic within the flow 665 
cytometric community [55].  666 
Table 5.  667 
List of monoclonal antibodies reactive with bovine antigens 668 
 669 
Specificity Clone Isotype Target specie Reference 
CD14 CAM36A IgG1 Bovine [139] 
CAM66A IgM Caprine [108] 
CC-G33 IgG1 Bovine [140] 
M5E2 IgG2a Human [141] 
MM61A IgG1 Bovine [142]  
TÜK4 IgG2a Human [143] 
VPM65 IgG1 Ovine [144] 
CD16 KD1 IgG2a Human [145] 
CD163 2A10/11 IgG1 Pig [17] 
EDHu-1 IgG1 Human [16] 
LND5A IgG1 Bovine [146] 
LND37A IgG1 Bovine [146] 
LND37A IgG1 Bovine [146] 
CD172a CC149 IgG2b Bovine [147] 
DH59B IgG1 Bovine [148] 
 670 
 671 
A typical stain/lyse/wash protocol is the following:  672 
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1) 100 µL of whole blood anticoagulated with Heparin [149] are labelled with saturating 673 
concentrations of monoclonal antibodies (Table 5) in a final volume of 120 μL with PBS (pH 674 
7.2), in a 5 mL polypropylene flow cytometric tube for 30 min at 4°C in the dark.  675 
2) Erythrocytes are lysed with 1.0 mL of Tris-buffered ammonium chloride solution (0.87% w/v, 676 
pH 7.3) for 10 min, then 2 mL of cold PBS are added 677 
3) The sample is centrifuged at 300 g for 5 min.  678 
4) Pellet of labelled cells is re-suspended with 200 μL of cold PBS and immediately acquired by 679 
flow cytometry.  680 
A simple indirect labelling protocol is done by introducing simple changes to the protocol previously 681 
described. In brief, whole blood is incubated under the same conditions with 0.75 µg of purified mAbs 682 
and then is processed in according to step 2 a 3. Pellet is re-suspended in 100 μL of fluorescent goat 683 
anti-mouse isotype-specific secondary mAbs and incubated for 15 min at 4°C in the dark. After the 684 
final wash, cells are re-suspended and acquired. 685 
Appropriate controls are necessary to evaluate auto-fluorescence, background staining and proper 686 
sample compensation, as well as to perform a careful antibody titration. 687 
The gating strategy to be used to identify the three subsets of monocytes should include: 1) time 688 
parameter vs FL or SSC to exclude event burst, 2) FSC-A vs FSC-H to exclude doublets, 3) exclusion 689 
of dead cells in the fluorescent live/dead channel, 4) FSC vs SSC to exclude debris and granulocytes 690 
from single live leukocytes, 5) CD172a vs CD16 dot plots to select CD172a positive mononuclear 691 
cells (all monocytes), 6) CD16 vs CD14 to separate cM subsets from intM and ncM, 7) back gating 692 
on dot plots 2, 3, and 4 to confirm the validity of the gating strategy.  693 
To avoid false positives, the use of the fluorescence minus one (FMO) control for quadrant positions 694 
of the dot plot CD16 vs CD14 is recommended. 695 
Pomeroy and coworkers [131] found a significant association between postpartum diseases (mastitis 696 
and metritis) and counts of monocyte subsets. Therefore, it is meaningful to evaluate the enumeration 697 
of absolute count of these subsets. Two different approaches can be used: dual-platform (flow 698 
cytometry and haematology) or single platform (flow cytometry). In the first method, the percentage 699 
of subsets (e.g. cM, intM, ncM) is measured with a flow cytometer while the absolute monocyte count 700 
is assessed by automated haematology analyzer. The absolute subset counts are therefore indirect. In 701 
the single-platform method, the flow cytometer is therefore used for directly counting monocyte 702 
subset in a given sample volume.  703 
In humans, the precise and accurate leukocyte subset count (e.g. CD4+ T cells in HIV patients, CD34+ 704 
for autotransplantation) is of primary importance, and the two methods have been extensively 705 
described [150]. According to European Working Group on Clinical Cell Analysis (EWGCCA) 706 
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[135], the single-platform method should be regarded as the gold standard for absolute cell 707 
assessments, and the use of stain/lyse/no-wash labelling protocols is recommended. 708 
 709 
9. Characterization of tissue macrophages via immunohistochemistry.  710 
Circulating monocytes migrate into various tissues and transform into macrophages. Macrophages 711 
have several roles in tissues monitoring, inflammation and repair representing one of the dominant 712 
cell types in chronic inflammatory reactions. 713 
Under non-inflammatory conditions, circulating monocytes localize in tissues and organs becoming 714 
resident macrophages to monitor healthy tissues. However, many resident macrophages are 715 
established before birth and then self- maintained during adult life. Resident macrophages are found 716 
in connective and adipose tissues, liver (Kupffer cells), splenic red pulp, bone marrow, lymph 717 
nodes, lung, brain, serous fluids, skin [151].  718 
Under inflammatory conditions, most of the macrophages that accumulate at diseased sites typically 719 
derive from circulating monocytes and take on several functions according to the inciting factors 720 
and milieu including antigen presentation, phagocytosis, and immunomodulation through the 721 
production of various cytokines and growth factors. Macrophages can be classified based on their 722 
function and activation pathways. According to this grouping, there are classically-activated (M1) 723 
macrophages, wound-healing macrophages (also known as alternatively-activated (M2) 724 
macrophages), and regulatory macrophages (Mregs) [23,152,153]. 725 
Macrophages can be activated directly by bacterial lipopolysaccharides, via TLR and extracellular 726 
matrix proteins. Under TH1 influence, macrophages react to IFN-γ, and TNF- to become 727 
classically activated M1 macrophages producing Nitric Oxide and Reactive Oxygen Species and 728 
upregulating lysosomal enzymes to kill ingested organisms or digest foreign substances [23,152]. In 729 
TH2 conditions macrophages act in response to IL-4, IL-5 and IL-13 by becoming wound healing 730 
M2 macrophages that secrete growth factors promoting angiogenesis, activating fibroblasts, and 731 
collagen synthesis [23,152]; under T regulatory secretion of IL-10 become regulatory/anti-732 
inflammatory Mreg macrophages producing IL-10 to suppress inflammation [153].  733 
 734 
9.1 Morphological characterization of macrophages: cytology and histology 735 
 736 
Following tissue entry and activation, monocytes in tissue undergo functional and morphological 737 
transformation into reactive macrophages that are morphologically readily recognizable. 738 
Thus, macrophages can be identified morphologically on cytological and histological specimens.  739 
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Cytological specimens are obtained by several techniques including imprints from tissues, scrapings 740 
to sample firm lesions which are less likely to exfoliate cells, swabs or by the needle aspiration 741 
technique. Sampled material by any of the aforementioned sampling methods can be smeared and 742 
air-dried [154]. Fluid specimens such as bronchoalveolar lavages, cerebrospinal fluid, articular fluid 743 
can be collected into an EDTA or a plain (if bacteriology is required) tube. Fluids can be 744 
cytocentrifuged or directly smeared according to their cellularity and again air-dried. Routine 745 
cytological stains are represented by alcohol‐based Romanowsky type stains including May‐746 
Grünwald‐Giemsa and Wright's stains [155].  747 
On cytological specimens, macrophages are easy to identify:  748 
a-Reactive macrophages (Fig. 6A ) are cells characterized by round to irregular shape, variably 749 
large size (averaging18-30 m), low N/C ratio, abundant light blue foamy to highly vacuolated 750 
cytoplasm with a paracentral to eccentric round to oval/reniform nucleus with granular chromatin 751 
and often one visible nucleolus. Macrophages phagocytize and degrade foreign exogenous or 752 
endogenous material and several etiological agents such as mycobacteria thus, they are recognized 753 
also because of their cytoplasmic content (Fig. 6B).  754 
b-Multinucleated macrophagic giant cells are cells developing in persistent granulomatous 755 
inflammation by fusion of two or more activated macrophages in the attempt to engulf and degrade 756 
large or undigestible material or organisms. Multinucleated giant macrophages can be extremely 757 
large (40-80 m), have two to multiple nuclei that may be haphazardly arranged termed foreign 758 
body type giant cells or have nuclei arranged at the periphery along the cell membrane in the so-759 
called horseshoe fashion. These cells are named Langhans cells and develop commonly but are not 760 
exclusive of tuberculosis in humans as in cows.  761 
c-Epithelioid macrophages develop in response to persistent intracellular pathogens such as 762 
mycobacteria. Epithelioid macrophages are characterized by large size, round to polygonal to 763 
spindle shape, abundant homogeneous light blue homogeneous, smooth cytoplasm with little to no 764 
vacuoles, an oval variably eccentric nucleus with finely granular chromatin. These cells are 765 
specialized in the production of cytokines and chemokines and do not have or have minimal 766 
phagocytic functions.  767 
In tissue specimens, macrophages, their architectural organization and possibly the engulfed 768 
causative agent can be viewed by histology. For histological evaluation, tissues are fixed in 10% 769 
neutral phosphate-buffered formalin. Fixation in formalin provides a standardized method to 770 
immortalize tissues providing with optimal tissue architecture and morphology. Formalin is a 771 
solution of Formaldehyde fixing by adducts crosslink (methylene bridges) firming the tissue. 772 
Fixation times vary according to with type and size of tissues with a penetrance of 1mm per hour of 773 
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a 1 mm3 tissue specimen with a volume of 1:10-1:20 with general fixation times of 24-48 h. 774 
Following adequate fixations, tissues are routinely processed, dehydrated in graded alcohol scales to 775 
remove free water, followed by tissue clearing (alcohol removal) in xylene and embedding in 776 
paraffin. Tissue sections of 3-6 m are cut, punt onto glass slides, dried, deparaffinized and stained 777 
routinely with hematoxylin and eosin. Macrophage morphology is similar to that described for 778 
cytological specimens (see the previous section) with observation or foamy reactive macrophages 779 
with pink to grey granular to vacuolated cytoplasm with variably distinct cell boundaries (Fig. 6C), 780 
multinucleated giant cells (Fig.6C and Fig. 6D) and epithelioid cells. Histopathology provides with 781 
reduced cellular detail compared with cytology, however, give relevant information regarding the 782 
organization of the inflammation. Specifically, granulomatous inflammation is a chronic 783 
inflammation in which monocyte-macrophages predominate. Granulomatous inflammation can be 784 
diffuse (lepromatous) with macrophages randomly dispersed in sheets (Fig. 6E ) or nodular 785 
(tuberculoid) with macrophages arranged in distinct masses termed granulomas (Fig. 6F). Diffuse 786 
granulomatous inflammation is currently believed to derive from TH2 driven stimuli while nodular 787 
granulomatous inflammation derives from the predominance of TH1 immunologic responses [156–788 
159]. The prototypic diffuse granulomatous inflammation in bovines is seen in Johne’ diseases 789 
where lamina propria of the intestine is expanded by sheets of macrophages (Fig. 6G associating to 790 
a heavy cytoplasmic burden of M. avium subsp. paratuberculosis (Fig. 6H) and often with minimal 791 
lymphoplasmacytic associated inflammation. In contrast, well-formed granulomas have a specific 792 
stratigraphy. The prototype of nodular tuberculoid granuloma develops in bovines and humans 793 
following M. bovis and M. tuberculosis infection. Granulomas in these conditions are generally 794 
paucibacillary. Histologically, granulomas are recognized as caseating that is with a central core of 795 
necrosis or non-caseating. Non-caseating granulomas contain a core of macrophages with variable 796 
epithelioid and multinucleated giant cells and may be surrounded by mature lymphocytes, plasma 797 
cells and rimmed by fibroblasts and collagen. Caseating granulomas have a similar arrangement but 798 
with variably extensive central areas of necrosis and can be seen in bovine (Fig. 6I) and human 799 
tuberculosis. In granulomas developing in the context of inflammatory reactions to persistent and 800 
poorly degradable antigens (e.g. Nocardia spp., Actinobacillus spp., Actinomyces spp., S. aureus) 801 
central accumulation of organisms rimmed and/or embedded in intensely eosinophilic material can 802 
be seen. This material represents the accumulation of immunoglobulins and is termed splendore-803 
Hoeppli phenomenon (Fig. 6J). Furthermore, granulomas can be also formed after vaccine or alum 804 
administration as described in many animal species including cats, dogs, swine, cattle and sheep. 805 
Histochemical stains for macrophage identification are occasionally applied and include lysozyme 806 
and acid phosphatase 5 [160] that however, should not be considered specific for macrophages.  807 
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 808 
9.2 Immunohistochemistry and Immunofluorescent characterization of macrophages. 809 
 810 
Immunohistochemistry and immunofluorescence are techniques that have been utilized to identify 811 
macrophages and macrophage subpopulations by definition of their antigen surface expression. The 812 
phenotype of macrophages has been evaluated on cytological specimens, [161] frozen tissues and 813 
formalin-fixed, paraffin-embedded tissue specimens. Immunofluorescence is a technique that 814 
provides the same information of immunohistochemistry (protein expression by a cell or a tissue) 815 
but by activation of fluorescent dyes. Compared to immunohistochemistry, immunofluorescence 816 
allows for single and double stains on tissues with an easier interpretation of co-expression of 817 
antigens. However, immunofluorescence stained tissues need to be kept in the dark and must be 818 
evaluated with a fluorescence microscope. Tissue sections stained with fluorescent dyes need to be 819 
analysed promptly since fluorescence intensity decays rapidly (few days to few weeks). Also, 820 
autofluorescence interferes with the detection of specific fluorescent signals, especially when the 821 
signals of interest are very dim. Immunofluorescence is generally applied to frozen tissue sections 822 
while is seldom applied to formalin-fixed and paraffin-embedded samples because of tissue 823 
processing associates with increased autofluorescence that may interfere with positive 824 
immunofluorescent signals especially if these are dim. Additionally, immunofluorescent expression 825 
of markers on tissue macrophages should be interpreted with care since degradation components 826 
such as lipofuscins accumulating in macrophage cytoplasm are autofluorescent. 827 
Immunohistochemistry is the most frequently applied technique to assess bovine macrophage 828 
phenotype in formalin-fixed tissue specimens, however, while formalin is the most common 829 
substance used worldwide for tissue fixation, induces cross-links (methylene bridges) that can block 830 
antibody access to antigenic epitopes or can damage surface antigens. To overcome antigen damage 831 
or masking caused by formalin fixation, immunofluorescence and immunohistochemistry can be 832 
applied to air-dried cytological specimens [162] or frozen tissue sections. Once the specimen is 833 
adequately sectioned immunohistochemistry and immunofluorescence techniques are similar. 834 
Immunohistochemistry on tissue sections has the advantage of visualizing protein expression in the 835 
context of the tissue, tissue lesion and specific cell type. This is less so for frozen specimens that 836 
bear inferior morphology and more so for immunofluorescence that reduces visualization of 837 
morphology. However, immunofluorescence is still favoured in specific studies because allows with 838 
easier double or multiple stains on tissues.  839 
For immunohistochemistry, 3-6-m sections are cut and put onto glued or charged slides to avoid 840 
detachment. Sections are deparaffinized and rehydrated using xylene and graded ethanol series. For 841 
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formalin-fixed tissue specimens in specific cases, antigen retrieval may be necessary. Antigen 842 
retrieval methods using enzymatic or heat-based protocols vary according to each molecular target 843 
and comprise: heat-induced (heating by pressure cookers or microwave in citrate buffer for 10 to 20 844 
min), enzymatic (0.1% trypsin or pepsin in phosphate-buffered saline for 30 min at 37°C) or 845 
proteinase K (10 μg/mL proteinase K in Tris buffer for 15 min) may be necessary [163–168]. 846 
Endogenous peroxidase is quenched with 3% H2O2 in PBS or 3% H2O2 in methanol for 20-30 847 
minutes to avoid false-positive results. Following washes in buffers, nonspecific antibody binding is 848 
inhibited by incubating tissues with blocking agents that vary according to primary and secondary 849 
antibody types and techniques. Primary antibody incubation temperatures (4-37°C) and times (1 850 
hour to overnight) vary according to the reagents and techniques with longer incubation times 851 
favoured for paraffin-embedded tissue sections [164]. Secondary biotinylated antibody incubation 852 
and signal amplification with different systems such as avidin-biotin (ABC), streptavidin-853 
peroxidase complexes are followed by visualization with chromogens such as 3, 3′-854 
diaminobenzidine or 3-Amino-9-ethyl carbazole (AEC) carbazole and counterstained with 855 
hematoxylin. 856 
For immunofluorescence, tissue specimens should be snap-frozen in isopentane cooled at the freezing 857 
temperature by immersion in liquid nitrogen. Frozen samples should be stored at -80˚C or cut on a 858 
cryostat immediately after freezing. For immunofluorescence, sections are dried and autofluorescence 859 
is quenched with 3-3 DAB. The following steps parallel those described for immunohistochemistry. 860 
Primary antibodies can be directly labelled with the fluorescent dyes thus the secondary antibodies 861 
and steps involving amplification of the signal and visualization with chromogens can be avoided. If 862 
primary antibodies are unconjugated, visualization is achieved by incubating the samples with the 863 
specific secondary antibody generally conjugated to rhodamine or FITC. Nuclei can be counterstained 864 
with 4’,6- diamidino-2-phenylindole, dihydrochloride (DAPI) or Hoechst 33342.  865 
Dual-colour immunofluorescence has been seldom applied to bovine tissues for macrophage 866 
evaluation [169]. 867 
29 
 
Table. 5  
List and details of molecular targets utilized for the immunohistochemical or immunofluorescent examination of bovine macrophages in formalin-
fixed or frozen tissue sections.  
Primary 
Ab Target  
Main cellular expression Known or proposed functions IHC/IF Ref. 
CD14 Monocytes, Macrophages Coreceptor for bacterial LPS, recruiting LPS to TLR, 
clearance of apoptotic cells,  
IF [169,170]  
 
CD11b Monocytes, Macrophages, 
natural killer cells, neutrophil 
granulocytes,  
Heterodimer binding to beta integrin CD18 (Mac-1 
complex) mediating leukocyte adhesion and migration 
IF [169] 
CD68 Monocytes, Macrophages, 
Osteoclasts 
Lysosomal membrane activated phagocytosis IHC, IF [138, 141–143] 
 
CD107b Placenta, lung and liver (wide 
tissue distribution),  
activated neutrophil 
granulocytes, activated 
platelets, activated T cells, 
activated endothelium 
Modulates chaperone-mediated autophagy. Decreases 
presentation of endogenous antigens by MHCII 
Maintenance of lysosomal integrity, pH and catabolism 
IF [160] 
CD163 Monocytes, Macrophages, M2 
polarization 
Acute phase-regulated receptor, clearance and 
endocytosis of haemoglobin/haptoglobin complexes by 
macrophages (protect tissues from free haemoglobin-
mediated oxidative damage). Innate immune sensor for 
bacteria inducer of proinflammatory cytokine production 
IF, IHC [136–138,144–
147]  
CD172a Neutrophil granulocytes, 
Monocytes, Macrophages M2 
polarization 
Receptor-type transmembrane glycoprotein negative 
regulator of receptor tyrosine kinase-coupled signalling  
IHC [175,176] 
 
CD204 Myeloid cells Endocytosis of modified/oxidized low-density 
lipoproteins   
IHC [163]  
CD206 Macrophages, 
Immature Dendritic cells 
Scavenger receptor that binding and internalization and 
lysosomal transport of microbial high mannose 
oligosaccharides   
IF [173]  
Iba-1  Activated macrophages,  Actin and calcium-binding protein with a role in 
Chemotaxis. Induced by cytokines and interferon promote 
IHC  [163,166,167,171] 
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Microglia, activated 
endothelial cells 
Neutrophils 
macrophage activation and growth of vascular smooth 
muscle cells and T-lymphocytes. 
Mac387 Granulocytes, Monocytes,  
Macrophages 
calcium- and zinc-binding protein with proinflammatory, 
antimicrobial, oxidant-scavenging and apoptosis-inducing 
activities.  
IHC [166]  
 
Nramp-1 Monocytes, Macrophages Role in resistance to intracellular bacterial pathogens IHC [165]  
 
CD14 ( Monocyte Differentiation Antigen CD14), CD11b (Integrin alpha), CD68 (Scavenger Receptor Class D, LAMP4, SCARD1), CD107b 
(Mac3, LAMP2-lysosomal associated membrane protein 2), CD163 (AM-3K, Scavenger Receptor Cysteine-Rich Type 1 Protein M130), CD172a 
(SIRPA, Signal Regulatory Protein Alpha), CD204 (MSR1, Macrophage scavenger receptor 1), CD206 (Mannose receptor MRC1), Iba-1 (Ionizing 
binding adaptor molecule 1, Allograft inflammatory factor 1 - AIF-1), Mac387 (Calprotectin beta chain), Nramp-1 (Natural resistance-associated 
macrophage protein 1)
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Table 6. List of molecular targets used for the immunohistochemical or immunofluorescent 
identification of bovine macrophage M1/M2 polarization in formalin-fixed or frozen tissue sections. 
  
Cytokine 
target 
M1/M2 
Polarization  
Technique Disease  Ref. 
IFN M1  IF, IHC Paratuberculosis  [166,173] 
IL1Ra M2  IF Paratuberculosis  [173] 
IL1- M1  
 
IF, IHC Paratuberculosis  
Contagious 
pleuropneumonia 
[173,177] 
IL-10 Mreg IF Paratuberculosis  [165,173] 
IL-12p40 M1  IF Paratuberculosis  [173] 
IL-17A M1  IHC Contagious 
pleuropneumonia 
[177] 
IL-23 M1  IF Paratuberculosis [173] 
iNOS M1  IHC Paratuberculosis [165]  
TGF- M2 IF, IHC Paratuberculosis [165,173] 
TLR4 
(CD284) 
M1  IF Paratuberculosis [173] 
TNF- M1  IF, IHC Paratuberculosis 
Contagious 
pleuropneumonia 
[165,173,177] 
uNOS  
(all NOS 
isoforms) 
M1  IF Paratuberculosis 
 
[173]  
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Several molecular targets have been utilized for the identification of bovine macrophages in 
formalin-fixed (Fig. 6K) or frozen tissue specimens. The molecular targets for macrophage 
recognition in cattle, their function and corresponding references are listed in Table 5.  
Immunohistochemistry and immunofluorescence have been utilized to identify, enumerate and 
characterize tissue macrophages in formalin-fixed [160,163–167,175–177] or frozen [168–170,172–
174] sections of a variety of bovine tissue samples including adipose tissue [160,167,168,175], in 
the intestinal tissue of cattle with spontaneous paratuberculosis at different stages of the disease 
[165,166,172–174], the endometrium of pregnant and post parturient dairy cows [169,170,176], 
fibrotic liver lesions in bovines infected with Fasciola hepatica [163], lung lesion in bovine 
contagious pleuropneumonia [177] and early lesions during experimental M. bovis aerosol infection 
[164].  
Polarization of M1-host defence macrophages versus M2-resolution/tissue repair macrophages has 
been investigated on tissue sections in bovine paratuberculosis and contagious bovine 
pleuropneumonia [165,173,177]. The target molecules assessed to study bovine macrophage 
polarization in tissues comprise several cytokines (Fig. 6L) and are listed in Table 6. Regarding 
macrophage polarization, the evaluation of CD163 expression as a specific marker form M2 
polarization has been questioned [174] because of its widespread expression in macrophages 
independently of disease stage of bovine paratuberculosis. Thus, CD163 is now favoured as a 
marker for all bovine macrophages and this reason has been listed in Table 5 and not in Table 6. 
Studies on paratuberculosis have demonstrated significantly higher numbers of M2 macrophages in 
the ileum of bovines with the clinical stage multibacillary lesions [165,173]. On the contrary, 
significant polarization versus M1 phenotype has been observed in paucibacillary lesions [166]. In 
lung lesions of contagious bovine pleuropneumonia, a general M1 polarization has been detected 
[177].  
10. Conclusions  
The present work reviews the current methods to classify in subpopulations and study the main 
functions of monocyte and macrophages in bovine species. The concept of monocyte/macrophage 
polarization in subsets has been validated and accepted in bovine species, and monocyte distribution 
in blood, and macrophage in tissues, mostly resembles that of human species. Indeed, new knowledge 
on monocyte and macrophage function basic biology and functions is needed to understand their 
impact on immune response in cows. Further studies are needed to demonstrate if monocytes can be 
further classified in subsets and to determine what is the function of each sub-set in bovine species as 
well. Among the various techniques applied so far, flow cytometry is the most promising and rapid 
method to identify new monocyte populations in bovine species and study their functions. The 
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application of flow cytometry in veterinary medicine has lagged behind human medical uses: the 
number of specific antibodies is limited, and the cross-reactivity of most of those available for human 
and murine studies is not validated in cows. The lack of specific reagents is what holds major 
challenges in advancing the knowledge in bovine monocytes. Lacking a labelled anti-Cd16 antibody 
allowing purification of ncM and intM is what prevents a full understanding of the functions of these 
important sub-classes of monocytes in the cow. Transcriptome analysis of resting and activated 
monocytes and macrophages is also limited to few studies: the role of different monocyte subset 
would be much more clear with a system biology approach by integrating transcriptome, metabolome, 
proteome and microRNAome of each subset after inflammatory activation.  
This information would provide important advancement in diagnosis and investigation of the 
pathogenesis of important cattle diseases, such for example tuberculosis, brucellosis or Johne’s 
disease that affect human health as well.  
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Figure Captions 
Fig. 1 Bovine peripheral blood smears.  
A. Normal round monocyte with a deeply indented nucleus and light blue homogeneous cytoplasm 
is present in a background of normal erythrocytes. Note the non-vacuolated cytoplasm, not all 
peripheral blood monocytes contain cytoplasmic vacuoles. Bar=7,2 m.  
B. Large peripheral blood monocyte with light blue non-vacuolated cytoplasm with an irregularly 
bean-shaped indented nucleus. Bar= 6 m.  
C. Large peripheral blood monocyte with irregular membrane contour and abundant light blue 
cytoplasm characterized by multiple, variably sized discrete cytoplasmic vacuoles. Bar= 4,9 m. 
May-Grünwald Giemsa stain.  
 
Fig. 2 Phase-contrast photomicrographs of cultured monocytes following MACS purification. 
A. Monocytes the first day in culture (10%FBS supplemented RPMI media). Bar= 20 m;  
B. Monocytes maintained for two days demonstrating a slight increase in size and shape and size 
variability. Bar=20 m.  
C. Two monocytes maintained for four days in culture and characterized by variably increased size 
and presenting with cytoplasmic processes indicative of activation and initial transformation into 
macrophages. Bar= 10 m.  
 
Fig. 3. Flow cytometry evaluation of monocytes, before and after sorting. 
PBMC are showed in a representative dot plot FSC vs SSC based on size and granularity (complexity) 
before (A) and after MACS separation (D). Monocytes staining with FITC-anti-CD14 antibody is 
showed before (B) and after sorting (E). Representative histograms of the relative percentage of 
lymphocytes and monocytes are showed before (C) and after sorting (F). MACS purification gives 
an enrichment of CD14+ monocytes population > of 98%. 
 
Fig. 4. Flow cytometry detection, by annexin V-FITC/PI, of apoptosis and necrosis on bovine 
PBMC incubated for 1 h at 37 °C.  
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On dot plot FSC vs SSC, a gate around lymphocytes and monocytes regions was drawn and apoptosis 
and necrosis in gated events were determined. Live lymphocytes (A) and monocytes (B) are Annexin 
V and PI double negative (lower left quadrant). At the early stage of apoptosis, the cells bind annexin 
V while still excluding PI (lower right quadrant). Double positive events are necrotic cells (upper 
right quadrant). The PI-positive - annexin V negative cells (upper left quadrant) are considered 
necroptotic cells [178]. 
 
Fig. 5. In vitro methods to measure chemotaxis  
(A) Schematic illustration of the Boyden chamber assay. Cells seeded in the upper chamber migrate 
through a porous membrane, towards the lower chamber in the response of a chemoattractant gradient 
concentration. (B) Schematic illustration of a migration transwell plate. The multiwell plate is 
packaged with permeable and removable cell culture inserts with a porous membrane that allows the 
migration of the cells towards the medium/chemoattractant-filled lower well. Images were created 
with BioRender.com". 
 
Fig. 6 Morphological and Immunohistochemical features of bovine macrophages in 
cytological and tissue specimens 
Fig. 6 A Cytology of synovial fluid in a calf with arthritis. Moderately cellular cytological sample 
illustrating numerous foamy reactive macrophages with variably abundant cytoplasm with 
numerous cytoplasmic vacuoles admixed with non-degenerate neutrophils in a background of 
confluent erythrocytes. Joint tap, May-Grünwald Giemsa stain. Bar= 25 µm 
Fig. 6 B Cytology of synovial fluid in a calf with arthritis. Large reactive macrophage with heavily 
vacuolated cytoplasm containing phagocytized apoptotic nuclear material. The macrophage is 
surrounded by moderately degenerated erythrocytes (crenation) and non-degenerated neutrophils in 
a granular background of synovial mucins. Joint tap, May-Grünwald Giemsa stain. Bar=7,5 µm 
Fig. 6 C Histology of a bovine mesenteric lymph node in a case of paratuberculosis. Sheets of 
reactive macrophages characterized by varying size, pink to grey cytoplasm and oval nuclei with 
granular to reticular chromatin and evidence of 1-2 small, basophilic nucleoli are admixed with 
mature lymphocytes and rare plasma cells. A single multinucleated macrophage with haphazardly 
arranged nuclei is evident (arrowhead). Haematoxylin and eosin stain. Bar= 14 m 
Fig. 6 D Histology of a bovine thoracic lymph node in a case of Tuberculosis. At the centre of the 
image, there is a large multinucleated giant macrophage characterized by several nuclei arranged in 
a horse-show fashion beneath the cell membrane. The cell is surrounded by occasional epithelioid 
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cells, foamy reactive macrophages with large cytoplasmic well distinct vacuoles and elevated 
numbers of lymphocytes (left) and lesser plasma cells. Haematoxylin and eosin stain. Bar= 32 m 
Fig. 6 E Bovine small intestine in a case of paratuberculosis. Lamina propria of intestinal villi is 
substituted and expanded by massive infiltration of large reactive macrophages displacing 
peripherally and compressing intestinal glands. Haematoxylin and eosin stain. Bar= 170 m 
Fig. 6 F Bovine tongue in a case of wooden tongue (Actinobacillus lignieresii infection). Large 
granuloma composed of reactive macrophages admixed with lesser numbers of neutrophils, 
eosinophils and lymphocytes and surrounded by fibroblasts and collagen). Haematoxylin and eosin 
stain. Bar= 75 m 
Fig. 6 G Bovine small intestine in a case of paratuberculosis. Diffuse granulomatous inflammation 
expanding and substituting the intestinal lamina propria with separation of the epithelial mucosal 
lining. Large reactive macrophages predominate and associate with lesser numbers of lymphocytes. 
In the left lower part of the image, an intestinal gland is compressed with gland epithelium lightly 
infiltrated by eosinophils (arrowhead). Haematoxylin and eosin stain. Bar= 64 m 
Fig. 6 H Bovine small intestine in a case of paratuberculosis. High numbers of acid-fast positive 
mycobacteria (Mycobacterium avium sbsp. paratuberculosis) in the cytoplasm of macrophages and 
free in the lamina propria. Ziehl – Neelsen stain. Bar= 22 m 
Fig. 6 I Bovine lung in a case of tuberculosis. The image shows the typical stratigraphy of a 
tuberculoid granuloma substituting the pulmonary parenchyma. The right and central parts of the 
image represent the extensive central area of caseous necrosis characterized by amorphous 
eosinophilic and granular basophilic tissue debris.  In the left part of the image, necrosis is rimmed 
by neutrophils, macrophages, multinucleated giant cells of the Langhans cell type and mature 
lymphocytes. The external portion of the granuloma is composed of fibroblasts and collagen 
delimiting the granuloma. Haematoxylin and eosin stain. Bar= 196 m 
Fig. 6 J Bovine tongue in a case of wooden tongue (Actinobacillus lignieresii infection). Discrete 
granuloma with central intensely eosinophilic material corresponding to the accumulation of 
immunoglobulin/immunocomplexes and termed Splendore-Hoeppli phenomenon. Haematoxylin 
and eosin stain. Bar= 110 m 
Fig 6 K Immunohistochemical stain of a bovine reactive thoracic lymph node. Numerous Iba-1 
positive reactive foamy macrophages in the medullary cords. Anti-Iba-1 immunoperoxidase stain, 
AEC chromogen, hematoxylin counterstain. Bar= 70 m 
Fig 6 L Immunohistochemical stain of a calf lung with bronchopneumonia. Alveolar lumen 
containing numerous reactive macrophages and rare neutrophils. Two M1 type macrophages 
intensely expressing TNF. Anti-TNF immunoperoxidase stain. AEC chromogen, hematoxylin 
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counterstain. Bar= 18 m 
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